# Francesco Paolo Schena

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francesco-paolo-schena/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,599 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 78 |
| i10-index | 245 |
| Last Known Institution | University of Bari Aldo Moro |
| OpenAlex ID | https://openalex.org/A5091868996 |
| ORCID iD | 0000-0001-7927-5207 |
| Works | 406 |

## Researcher papers

Showing 12 of 15.

- [The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-rationale-clinicopathological/)
- [The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-pathology-definitions-correlations/)
- [Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients](https://scholariq.org/papers/sirolimus-for-kaposi-s-sarcoma-in-renal-transplant-recipients/)
- [Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria](https://scholariq.org/papers/renoprotective-properties-of-ace-inhibition-in-non-diabetic-nephropathies-with/)
- [Pathogenetic Mechanisms of Diabetic Nephropathy](https://scholariq.org/papers/pathogenetic-mechanisms-of-diabetic-nephropathy/)
- [Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial](https://scholariq.org/papers/conversion-from-calcineurin-inhibitors-to-sirolimus-maintenance-therapy-in-renal/)
- [IgA nephropathy](https://scholariq.org/papers/iga-nephropathy-2/)
- [Epidemiology of IgA Nephropathy: A Global Perspective](https://scholariq.org/papers/epidemiology-of-iga-nephropathy-a-global-perspective/)
- [Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review](https://scholariq.org/papers/effects-of-angiotensin-converting-enzyme-inhibitors-and-angiotensin-ii-receptor/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)
- [IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23](https://scholariq.org/papers/iga-nephropathy-the-most-common-cause-of-glomerulonephritis-is-linked-to-6q22-23/)
- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

## Researcher university

- [University of Bari Aldo Moro](https://scholariq.org/institutions/university-of-bari-aldo-moro/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.